Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
27
Number of overlapping holdings
12.6%
% of BTEC's 220 holdings also in BBP
51.9%
% of BBP's 55 holdings also in BTEC
Overlap by Weight
Sector Drift (BTEC minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BTEC |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
SAREPTA THERAPEUTICS INC | 2.6% | 2.4% | 2.4% |
|
APELLIS PHARMACEUTICALS, INC. | 1.7% | 2.2% | 1.7% |
|
INTRA-CELLULAR THERAPIES INC | 1.6% | 2.0% | 1.6% |
|
IONIS PHARMACEUTICALS, INC. | 1.5% | 1.6% | 1.5% |
|
ALNYLAM PHARMACEUTICALS INC | 2.3% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
BTEC Overweight Relative to BBP
|
KARUNA THERAPEUTICS, INC. | 2.7% |
|
EXACT SCIENCES CORP | 2.4% |
|
NATERA INC | 2.3% |
|
BIO-RAD LABORATORIES-CL A | 2.2% |
|
ILLUMINA INC | 2.0% |
|
ELANCO ANIMAL HEALTH, INC. | 1.8% |
|
CYTOKINETICS INC | 1.7% |
|
VAXCYTE, INC. | 1.6% |
|
CEREVEL THERAPEUTICS HOLDINGS INC | 1.5% |
|
INSPIRE MEDICAL SYSTEMS, INC. | 1.2% |
BTEC Underweight Relative to BBP
|
TARSUS PHARMACEUTICALS, INC. | -3.5% |
|
LEXICON PHARMACEUTICALS, INC. | -3.4% |
|
CRISPR THERAPEUTICS AG | -2.4% |
|
ASCENDIS PHARMA A/S | -2.3% |
|
ADMA BIOLOGICS, INC. | -2.1% |
|
AGIOS PHARMACEUTICALS INC | -2.0% |
|
REGENERON PHARMACEUTICALS | -2.0% |
|
KINIKSA PHARMACEUTICALS LTD. CLASS A | -2.0% |
|
MODERNA, INC. | -2.0% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.0% |